Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

Laurus aims to leverage India's manufacturing prowess to serve global cell and gene therapy players targeting the Indian ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Cell therapy is emerging as a cutting-edge precision ... potential to change this landscape dramatically. The global cell-based ophthalmic therapies market was valued at $1.2 billion in 2023 ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

The haematologist-oncologist is continuing his path of helping cancer patients by reducing the costs of one of the most ...

Patients who continued to receive pembrolizumab-based therapy after disease progression had longer overall survival than patients who stopped receiving pembrolizumab-based therapy.

In CAR-based therapy, T cells are engineered to target and kill cells that express a specific molecule. CAR T cells have been highly successful in individuals with B cell leukemia/lymphoma and ...